Rang	Name	Position
1	Mr. Bernard J. Zovighian	CEO & Director
2	Mr. Donald E. Bobo Jr.	Corporate Vice President of Strategy & Corporate Development
3	Mr. Daveen Chopra	Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies
4	Ms. Annette Maria Bruls	Corporate Vice President of EMEA, Canada, & Latin America
5	Ms. Theodora Mistras	Corporate VP & CFO
6	Mr. Joseph Nuzzolese	Corporate Vice President of Global Operations & Quality
7	Mr. Andrew M. Dahl	Principal Accounting Officer, Senior VP & Corporate Controller
8	Dr. Todd Brinton FACC, M.D.	Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer
9	Mr. Snehashish Sarkar	Senior VP and Chief Information & Digital Officer
10	Mr. Mark D. Peterson	Corporate VP & General Counsel

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	9,12%	4,44 Mrd. USD
2	Vanguard Capital Management, LLC	6,55%	3,18 Mrd. USD
3	Vanguard Portfolio Management, LLC	4,58%	2,23 Mrd. USD
4	State Street Corp	4,56%	2,22 Mrd. USD
5	JPMorgan Chase & Co	3,77%	1,84 Mrd. USD
6	Wellington Management Company LLP	2,92%	1,42 Mrd. USD
7	Bank of New York Mellon Corp	2,90%	1,41 Mrd. USD
8	FMR Inc	2,52%	1,22 Mrd. USD
9	Geode Capital Management, LLC	2,28%	1,11 Mrd. USD
10	DZ BANK AG Deutsche Zentral-Genossenschaftsbank Frankfurt am Main	2,22%	1,08 Mrd. USD
11	Ninety One UK Limited	2,14%	1,04 Mrd. USD
12	NORGES BANK	1,45%	0,71 Mrd. USD
13	Morgan Stanley - Brokerage Accounts	1,23%	0,60 Mrd. USD
14	Brown Advisory Holdings Inc	1,22%	0,59 Mrd. USD
15	Artisan Partners Limited Partnership	1,15%	0,56 Mrd. USD
16	Deutsche Bank AG	1,05%	0,51 Mrd. USD
17	Northern Trust Corp	1,01%	0,49 Mrd. USD
18	UBS Asset Mgmt Americas Inc	0,95%	0,46 Mrd. USD
19	The Goldman Sachs Group Inc	0,88%	0,43 Mrd. USD
20	Amvescap Plc.	0,84%	0,41 Mrd. USD